Vimarsana
Biggest News Aggregation in the World

Page 26 - Controlled Trials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Controlled Trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Controlled Trials Today - Breaking & Trending Today

The Effect of Intense LDL-C–Lowering on Ischemic Stroke With Atherosclerosis - Vimarsana News

The Effect of Intense LDL-C–Lowering on Ischemic Stroke With Atherosclerosis

Patients with a history of ischemic stroke and atherosclerosis benefitted from more intense LDL cholesterol-lowering statin-based therapies for recurrent stroke risk reduction.

Scientific measurement won't answer all questions in education. We need teacher and student voices, too - Vimarsana News

Scientific measurement won't answer all questions in education. We need teacher and student voices, too

Privileging the randomised controlled trial in education suggests a preoccupation with scientific measurement over research that privileges participants’ voices, especially in a feminised profession.

Visualising health risks with medical imaging for changing recipients' health behaviours and risk factors: Systematic review with meta-analysis - Vimarsana News

Visualising health risks with medical imaging for changing recipients' health behaviours and risk factors: Systematic review with meta-analysis

In a systematic review and meta-analysis, Gareth Hollands and colleagues study the relationship between receipt of visual feedback of results following medical imaging procedures and risk-reducing health-related behaviors.

Source: plos.org
Calcium Channel Blockers Vs Other Classes of Antihypertension Drugs - Vimarsana News

Calcium Channel Blockers Vs Other Classes of Antihypertension Drugs

A meta-analysis found mixed evidence that CCBs are superior or inferior to any specific other antihypertensive drug at reducing major CV events.

Cureus | Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α) as a Regulator of the Angiogenic Profile of Endometriotic Lesions - Vimarsana News

Cureus | Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α) as a Regulator of the Angiogenic Profile of Endometriotic Lesions

Endometriosis is a disease that affects a significant proportion of women and its infiltrative pattern is entirely dependent on the vascular supply of lesions. Several factors seem to trigger the process of angiogenesis in endometriotic lesions. During the last years, peroxisome proliferator-activated receptors (PPARs), a group of nuclear proteins that regulate gene transcription and that seem to regulate energy consumption and expenditure, have been also implicated in the pathophysiology of angiogenesis. Their ability to regulate the course of cancer and improve the survival rates of patients...

Source: cureus.com